BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6038793)

  • 1. Comparative antimony disposition following administration of tartar emetic and sodium antimony dimercaptosuccinate (Astiban) to hamsters infected with Schistosoma mansoni.
    Schulert AR; Girgis NI; Girgis GR; Farid Z; McConnell E
    East Afr Med J; 1967 Jan; 44(1):1-8. PubMed ID: 6038793
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of penicillamine as an adjuvant to tartar emetic in the treatment of experimental schistosomiasis.
    Khayyal MT; Girgis NI; McConnell E
    Bull World Health Organ; 1967; 37(3):387-92. PubMed ID: 5301382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIOLOGICAL DISPOSITION OF SOME ANTIMONYL ANTIBILHARZIAL DRUGS: SODIUM ANTIMONY-2,3-MESO-DIMERCAPTO-SUCCINATE (ASTIBAN) IN ANIMALS INFECTED WITH SCHISTOSOMA MANSONI.
    BROWNE HG; SCHULERT AR
    Am J Trop Med Hyg; 1964 Jul; 13():558-71. PubMed ID: 14196053
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppressive therapy with MsbE and Astiban in hamsters infected with Schistosoma mansoni.
    Baldewsing R
    Trop Geogr Med; 1973 Jun; 25(2):174-8. PubMed ID: 4736841
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of penicillamine in the treatment of experimental schistosomiasis with tartar emetic.
    Tarrant ME; Wedley S; Woodage TJ
    Ann Trop Med Parasitol; 1971 Jun; 65(2):233-44. PubMed ID: 5090262
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral tracer sodium antimony-2, 3-meso-dimercapto-succinate (Astiban) in hamsters infected with Schistosoma mansoni.
    Girgis GR; Girgis NI; Schulert AR; McConnell E
    J Egypt Public Health Assoc; 1966; 41(4):237-42. PubMed ID: 6002838
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study on two labelled antimonial drugs, Bilharcid and tartar emetic using monkeys.
    Abdel-Wahab MF; Abdulla WA; Nasr A; El-Garhi MZ; Kamel S
    Egypt J Bilharz; 1974; 1(1):101-6. PubMed ID: 4219880
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of glucosamine in increasing the efficacy of tartar emetic in experimental schistosomiasis.
    Girgis NI; Mansour NS; Khayyal MT; Henry W
    J Egypt Public Health Assoc; 1972; 47(2):81-7. PubMed ID: 5046582
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of the antibilharzial compound (Bilharcid) on Schistosoma mansoni in vitro and in vivo.
    Mahran SG; Shehata H; Abdulla WA; el-Raziky EH
    Egypt J Bilharz; 1976; 3(2):239-45. PubMed ID: 1037637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: DISTRIBUTION OF ANTIMONY-124 IN MICE AND HAMSTERS AFTER A SINGLE DOSE OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND ANTIMONY DIMERCAPTOSUCCINIC ACID.
    THOMMEN H; STOHLER HR; WUERSCH J; FREY JR
    Ann Trop Med Parasitol; 1964 Dec; 58():439-52. PubMed ID: 14249023
    [No Abstract]   [Full Text] [Related]  

  • 11. SODIUM ANTIMONY DIMERCAPTO-SUCCINATE VERSUS TARTAR EMETIC IN THE TREATMENT OF BILHARZIASIS BY VARIOUS SPACED DOSAGE SCHEMES IN EGYPT, U.A.R.
    ABDALLAH A; SAIF M
    J Egypt Med Assoc; 1964; 47():427-38. PubMed ID: 14263409
    [No Abstract]   [Full Text] [Related]  

  • 12. Astiban therapy of Schistosoma mansoni infection: a quantitative evaluation.
    Farid Z; Bassily S; McConnell E; Davis J
    Ann Trop Med Parasitol; 1967 Sep; 61(3):310-4. PubMed ID: 5625700
    [No Abstract]   [Full Text] [Related]  

  • 13. CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: PROPHYLACTIC, PROTECTIVE AND THERAPEUTIC ACTIVITY OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND ANTIMONY DIMERCAPTOSUCCINIC ACID IN MICE AND HAMSTERS.
    STOHLER HR; FREY JR
    Ann Trop Med Parasitol; 1964 Sep; 58():280-91. PubMed ID: 14212884
    [No Abstract]   [Full Text] [Related]  

  • 14. Physiological disposition of antimony after administration of 124Sb-labelled tartar emetic to rats, mice and monkeys, and the effects of tris (p-aminophenyl) Carbonium pamoate on this distribution.
    Waitz JA; Ober RE; Meisenhelder JE; Thompson PE
    Bull World Health Organ; 1965; 33(4):537-46. PubMed ID: 5294998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study of the absorption and elimination of astiban labelled with 124Sb.
    de Azevedo JF; Gil FB; Barreira F; da Rocha RM; Monteiro OS
    An Inst Med Trop (Lisb); 1966; 23(1):3-10. PubMed ID: 5986694
    [No Abstract]   [Full Text] [Related]  

  • 16. The "lung shift" of Schistosoma mansoni in mice following therapy with tartar emetic or miracil D.
    HEWITT R; GILL E
    Am J Trop Med Hyg; 1960 Jul; 9():402-9. PubMed ID: 14401609
    [No Abstract]   [Full Text] [Related]  

  • 17. The carbohydrate metabolism of Schistosoma mansoni and some effects of ambilhar and astiban.
    Magzoub M; Fletcher KA; Maegraith BG
    Trans R Soc Trop Med Hyg; 1969; 63(1):16. PubMed ID: 5789093
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic evaluation of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].
    Siqueira MW; Huggins D
    Rev Bras Med; 1967 Feb; 24(2):97-9. PubMed ID: 5604907
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycolytic activities of Schistosoma mansoni and the mode of action of antischistosomal drugs (Ambilhar and Astiban).
    Magzoub M; Maegraith BG
    Ann Trop Med Parasitol; 1969 Sep; 63(3):377-91. PubMed ID: 5373668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic use of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].
    Teixeira D; de Gouveia OF; Miyahira AR; Galper E; da Cunha MA
    Hospital (Rio J); 1965 Dec; 68(6):1361-75. PubMed ID: 5296034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.